Home » BAYER'S SCHERING BUY UNCONDITIONALLY CLEARED BY EU
BAYER'S SCHERING BUY UNCONDITIONALLY CLEARED BY EU
The European Commission said it has cleared the proposed acquisition of the German pharmaceutical company Schering AG by Bayer AG also of Germany. The commission said the activities of the parties are mainly complementary with the main overlaps in a few over-the-counter (OTC) and prescription antifungal markets.
Euro2Day
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May